MicroRNA 3123 (MIR3123)

MicroRNA 3123 (MIR3123) is a short non-coding RNA (about 20–24 nucleotides) classified as a microRNA (miRNA). Like other miRNAs, it functions primarily in multicellular organisms to regulate gene expression at the post-transcriptional level by binding complementary sequences within target messenger RNAs (mRNAs). This binding typically leads to translational inhibition or mRNA destabilization, executed through RNA-induced silencing complexes (RISC). MIR3123 has been associated with stomach carcinoma in situ, but no further detailed disease roles or drug interactions are currently established. It is one of many non-coding RNAs involved in fundamental processes such as cell differentiation, proliferation, and survival [1][2][4][5]. Key points: - MIR3123 is not considered a classic “therapeutic target” like enzymes or receptors; miRNAs are generally regulators rather than direct drug targets [1][2]. - The typical miRNA regulatory mechanisms include mRNA cleavage, translational repression, and impacts on mRNA stability, but specific validated roles or targets for MIR3123 are not reported. - MIR3123's presence in disease (e.g., cancer) hints at possible biomarker utility, as is the case for several circulating miRNAs, although supporting evidence or clinical implementation for MIR3123 is currently lacking [1][2][6].

Other names

hsa-mir-3123mir-3123MIR3123